FDA approves new formulation of HIV treatment drug

ABBOTT PARK, Ill. The Food and Drug Administration has approved a new formulation of an anti-retroviral drug for treating HIV made by Abbott, the drug maker announced.

The FDA approved a tablet form of the drug Norvir (ritonavir) in the 100 mg strength. The tablets, meant for use in combination with other anti-retroviral drugs to treat HIV, can be stored at room temperature and do not require refrigeration. The soft-gel capsule and liquid forms of the drug will remain available in the United States.

“Norvir has been a critical component of HIV treatment for many patients,” Abbott divisional VP infections disease development Scott Brun said in a statement. “The innovation behind the development of the Norvir tablet is the direct result of years of effort by Abbott scientists to address the needs of people living with HIV.”

Login or Register to post a comment.